InsiderTrades

Form 4 for LMAT LEMAITRE VASCULAR INC

Accepted 2025-12-15 00:00:00 ET · period of report 2025-12-11 · accession 0001193125-25-319550 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-15 2025-12-11+ LMAT Kamke Trent G Senior V. P, Ops M - OptEx $0.00 +27 4,671 +0.6% $0
DM 2025-12-15 2025-12-11+ LMAT Kamke Trent G Senior V. P, Ops F - Tax $83.79 -270 4,581 -6% -$22.6K
DM 2025-12-15 2025-12-11+ LMAT Kamke Trent G Senior V. P, Ops M - OptEx $0.00 -27 8.73 -76% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-12 M A 8 $0.00 4,507 D — — (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
2 Common Common Stock 2025-12-12 F D 90 $84.00 4,417 D — — (F4) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
3 Common Common Stock 2025-12-12 F D 90 $84.00 4,499 D — — (F3) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
4 Common Common Stock 2025-12-12 M A 8 $0.00 4,589 D — — (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
5 Common Common Stock 2025-12-11 F D 90 $83.36 4,581 D — — (F2) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
6 Common Common Stock 2025-12-11 M A 11 $0.00 4,671 D — — (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
7 Derivative Dividend Equivalent Rights 2025-12-11 M D 11 $0.00 0 D — · — to — 11 Common Stock (F5) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. (F6) Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.
8 Derivative Dividend Equivalent Rights 2025-12-12 M D 8 $0.00 8.73 D — · — to — 8 Common Stock (F7) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
9 Derivative Dividend Equivalent Rights 2025-12-12 M D 8 $0.00 8.73 D — · — to — 8 Common Stock (F8) These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.